Innovative array-based assay for omics pattern in melanoma

References

• Ancuceanu, R.; Neagu, M. Immune based Therapy for Melanoma. Ind. J. Med. Res. 2016, 143(2), 135–144.
   PubMed Web of Science ®Google Scholar
• Gandolfi, G.; Dallaglio, K.; Longo, C.; Moscarella, E.; Lallas, A.; Alfano, R.; Argenziano, G.; Ciarrocchi, A. Contemporary and Potential Future Molecular Diagnosis of Melanoma. Expert Rev. Mol. Diagn. 2016, 16(9), 975–985.
   PubMed Web of Science ®Google Scholar
• Blumenberg, M. Skinomics: Past, Present and Future for Diagnostic Microarray Studies in Dermatology. Exp. Rev. Mol Diagn. 2013, 13(8), 885–894.
   PubMed Web of Science ®Google Scholar
• Bulman, A.; Neagu, M.; Constantin, C. Immunomics in Skin Cancer-improvement in Diagnosis, Prognosis and Therapy Monitoring, Curr Proteom. 2013, 10(3), 202–217.
   Google Scholar
• Hua, L.; Zheng, W.Y.; Xia, H.; Zhou, P. Detecting the Potential Cancer Association or Metastasis by Multi-omics Data Analysis. Genet. Mol. Res. 2016, 15(3), 1–15.
   Web of Science ®Google Scholar
• Jiang, Y.; Shi, X.; Zhao, Q.; Krauthammer, M.; Rothberg, B.E.; Ma, S. Integrated Analysis of Multidimensional Omics Data on Cutaneous Melanoma Prognosis. Genomics 2016, 107(6), 223–230.
   PubMed Web of Science ®Google Scholar
• Jayawardana, K.; Schramm, S.J.; Haydu, L.; Thompson, J.F.; Scolyer, R.A.; Mann, G.J.; Müller, S.; Yang, J.Y. Determination of Prognosis in Metastatic Melanoma through Integration of Clinico-pathologic, Mutation, mRNA, microRNA, and Protein Information. Int. J. Cancer 2015, 136(4), 863–874.
   PubMed Web of Science ®Google Scholar
• Welinder, C.; Jönsson, G.; Ingvar, C.; Lundgren, L.; Olsson, H.; Breslin, T.; Végvári, A.; Laurell, T.; Rezeli, M.; Jansson, B.; Baldetorp, B.; Marko-Varga, G. Establishing a Southern Swedish Malignant Melanoma OMICS and Biobank Clinical Capability. Clin. Transl. Med. 2013, 2(1), 7.
   PubMedGoogle Scholar
• Dummer, R.; Goldinger, S.M.; Paulitschke, V.; Levesque, M.P. Curing Advanced Melanoma by 2025. Curr. Opin. Oncol. 2015, 27(2), 125–127.
   Google Scholar
• Tsimberidou, A.M.; Eggermont, A.M.; Schilsky, R.L. Precision Cancer Medicine: The Future is Now, Only Better. Am. Soc. Clin. Oncol. Educ. Book. 2014, 61–69.
   PubMedGoogle Scholar
• Yoshikawa, S.; Kiyohara, Y.; Otsuka, M.; Kondou, R.; Nonomura, C.; Miyata, H.; Iizuka, A.; Ohshima, K.; Urakami, K.; Nagashima, T.; Kusuhara, M.; Sugino, T.; Mochizuki, T.; Yamaguchi, K.; Akiyama, Y. Multi-omics Profiling of Patients with Melanoma Treated with Nivolumab in Project HOPE. Anticancer Res. 2017, 37(3), 1321–1328.
   PubMed Web of Science ®Google Scholar
• Shtivelman, E.; Davies, M.Q.; Hwu, P.; Yang, J.; Lotem, M.; Oren, M.; Flaherty, K.T.; Fisher, D.E. Pathways and Therapeutic Targets in Melanoma. Oncotarget 2014, 5(7), 1701–1752.
   PubMed Web of Science ®Google Scholar
• Overwijk, W.W.; Wang, E.; Marincola, F.M.; Rammensee, H.G.; Restifo, N.P. Mining the Mutanome: Developing Highly Personalized Immunotherapies based On Mutational Analysis of Tumors. J. Immunother. Cancer. 2013, 1, 11.
   PubMedGoogle Scholar
• Riegel, M. Human Molecular Cytogenetics: From Cells to Nucleotides. Genet Mol Biol. 2014, 37(1 Suppl), 194–209.
   PubMed Web of Science ®Google Scholar
• Przybytkowski, E.; Aguilar-Mahecha, A.; Nabavi, S.; Tonellato, P.J.; Basik, M. Ultradense Array CGH and Discovery of Micro-copy Number Alterations and Gene Fusions in the Cancer Genome. Meth. Mol Biol. 2013, 973, 15–38.
   PubMedGoogle Scholar
• Urban, A.E.; Korbel, J.O.; Selzer, R.; Richmond, T.; Hacker, A.; Popescu, G.V.; Cubells, J.F.; Green, R.; Emanuel, B.S.; Gerstein, M.B.; Weissman, S.M.; Snyder, M. High-resolution Mapping of DNA Copy Alterations in Human Chromosome 22 using High-density Tiling Oligonucleotide Arrays. Proc. Natl. Acad. Sci., USA. 2006, 103( 12), 4534–4539.
   Google Scholar
• Curtis, C.; Lynch, A.G.; Dunning, M.J.; Spiteri, I.; Marioni, J.C.; Hadfield, J.; Chin, S.F.; Brenton, J.D.; Tavare, S.; Caldas, C. The Pitfalls of Platform Comparison: DNA Copy Number Array Technologies Assessed. BMC Genom. 2009, 10, 588.
   PubMed Web of Science ®Google Scholar
• Oostlander, A.E.; Meijer, G.A.; Ylstra, B. Microarray-based Comparative Genomic Hybridization and its Applications in Human Genetics. Clin Genet. 2004, 66(6), 488–495.
   PubMed Web of Science ®Google Scholar
• Inaoka, K.; Inokawa, Y.; Nomoto, S. Genomic-Wide Analysis with Microarrays in Human Oncology. Microarrays (Basel). 2015, 4(4), 454–473.
   PubMedGoogle Scholar
• Klopfleisch, R.; Weiss, A.T.; Gruber, A.D. Excavation of a Buried Treasure—DNA, mRNA, miRNA and Protein Analysis in Formalin Fixed, Paraffin Embedded Tissues. Histol. Histopathol. 2011, 26(6), 797–810.
   PubMed Web of Science ®Google Scholar
• Stanta, G.; Jahn, S.W.; Bonin, S.; Hoefler, G. Tumour Heterogeneity: Principles and Practical Consequences. Virchows Arch. 2016, 469(4), 371–384.
   PubMed Web of Science ®Google Scholar
• Nowak, N.J.; Miecznikowski, J.; Moore, S.R.; Gaile, D.; Bobadilla, D.; Smith, D.D.; Kernstine, K.; Forman, S.J.; Mhawech-Fauceglia, P.; Reid, M.; Stoler, D.; Loree, T.; Rigual, N.; Sullivan, M.; Weiss, L.M.; Hicks, D.; Slovak, M.L. Challenges in Array Comparative Genomic Hybridization for the Analysis of Cancer Samples. Genet. Med. 2007, 9(9), 585–595.
   PubMed Web of Science ®Google Scholar
• Ruiz, C.; Lenkiewicz, E.; Evers, L.; Holley, T.; Robeson, A.; Kiefer, J.; Demeure, M.J.; Hollingsworth, M.A.; Shen, M.; Prunkard, D.; Rabinovitch, P.S.; Zellweger, T.; Mousses, S.; Trent, J.M.; Carpten, J.D.; Bubendorf, L.; Von Hoff, D.; Barrett, M.T. Advancing a Clinically Relevant Perspective of the Clonal Nature of Cancer. Proc. Natl. Acad. Sci. U S A. 2011, 108(29), 12054–12059.
   PubMed Web of Science ®Google Scholar
• Wang, L.; Rao, M.; Fang, Y.; Hameed, M.; Viale, A.; Busam, K.; Jhanwar, S.C. A Genome-wide High-resolution Array-CGH Analysis of Cutaneous Melanoma and Comparison of Array-CGH to FISH in Diagnostic Evaluation. J. Mol. Diagn. 2013, 15(5), 581–591.
   PubMed Web of Science ®Google Scholar
• Heitzer, E.; Auer, M.; Gasch, C.; Pichler, M.; Ulz, P.; Hoffmann, E.M.; Lax, S.; Waldispuehl-Geigl, J.; Mauermann, O.; Lackner, C.; Höfler, G.; Eisner, F.; Sill, H.; Samonigg, H.;Pantel, K.; Riethdorf, S.; Bauernhofer, T.; Geigl, J.B.; Speicher, M.R. Complex Tumor Genomes Inferred from Single Circulating Tumor Cells by Array-CGH and Next-generation Sequencing. Cancer Res. 2013, 73(10), 2965–2975.
   PubMed Web of Science ®Google Scholar
• Zurac, S.; Negroiu, G.; Petrescu, S.; Andrei, R.; Tebeica, T.; Popp, C.; Musţată, R.; Neagu, M.; Constantin, C.; Solovan, C.; Chiţu, V.; Reboşapcă, A.; Andreescu, B.; Marinescu, I.; Stăniceanu, F. Spectrum of Morphologic Alterations of Regression in Cutaneous Melanoma—Potential for Improving Disease Prognosis. Rom. J. Intern. Med. 2012, 50(2), 145–153.
   PubMedGoogle Scholar
• Tanase, C.P.; Albulescu, R.; Neagu, M. Application of 3D Hydrogel Microarrays in Molecular Diagnostics: Advantages and Limitations. Exp. Rev. Mol. Diagn. 2011, 11(5), 461–464.
   Google Scholar
• Moore, D.A.; Pringle, J.H. Saldanha, G.S. Prognostic Tissue Markers in Melanoma. Histopathology 2012, 60(5), 679–689.
   PubMed Web of Science ®Google Scholar
• O’Hagan, R.C.; Brennan, C.W.; Strahs, A.; Zhang, X.; Kannan, K.; Donovan, M.; Cauwels, C.; Sharpless, N.E.; Wong, W.H.; Chin, L. Array Comparative Genome Hybridization for Tumor Classification and Gene Discovery in Mouse Models of Malignant Melanoma. Cancer Res. 2003, 63(17), 5352–5356.
   PubMed Web of Science ®Google Scholar
• Diaconeasa, A.; Boda, D.; Solovan, C.; Enescu, D.M.; Vîlcea, A.M.; Zurac, S. Histopathologic Features of Spitzoid Lesions in Different Age Groups. Rom. J. Morphol. Embryol. 2013, 54(1), 51–62.
   PubMed Web of Science ®Google Scholar
• Redon, S.; Guibourg, B.; Talagas, M.; Marcorelles, P.; Uguen, A. A Diagnostic Algorithm Combining Immunohistochemistry and Molecular Cytogenetics to Diagnose Challenging Melanocytic Tumors. Appl. Immunohistochem. Mol. Morphol. 2017, Mar 30, doi: 10.1097/PAI.0000000000000511. [Epub ahead of print]
   Google Scholar
• Harvell, J.D.; Kohler, S.; Zhu, S.; Hernandez-Boussard, T.; Pollack, J.R.; van de Rijn, M. High-resolution Array-based Comparative Genomic Hybridization for Distinguishing Paraffin-embedded Spitz Nevi and Melanomas. Diagn. Mol. Pathol. 2004, 13(1), 22–25.
   PubMedGoogle Scholar
• Ali, L.; Helm, T.; Cheney, R.; Conroy, J.; Sait, S.; Guitart, J.; Gerami, P. Correlating Array Comparative Genomic Hybridization Findings with Histology and Outcome in Spitzoid Melanocytic Neoplasms. Int. J. Clin. Exp. Pathol. 2010, 3(6), 593–599.
   PubMed Web of Science ®Google Scholar
• Mesbah Ardakani, N.; Thomas, C.; Robinson, C.; Mina, K.; Harvey, N.T.; Amanuel, B.; Wood, B.A. Detection of Copy Number Variations in Melanocytic Lesions Utilising Array Based Comparative Genomic Hybridisation Pathology. 2017, 49(3), 285–291.
   Google Scholar
• Andrei, R.; Zurac, S.; Socoliuc, C.; Mandisodza, P.; Staniceanu, F. Problems of Differential Diagnosis in Melanoma Arising from Blue Naevus. Rom. J. Intern. Med. 2015, 53(1), 95–101.
   PubMedGoogle Scholar
• Nedelcu, R.I.; Zurac, S.A.; Brînzea, A.; Cioplea, M.D.; Turcu, G.; Popescu, R.; Popescu, C.M.; Ion, D.A. Morphological Features of Melanocytic Tumors with Depigmented Halo: Review of the Literature and Personal Results. Rom. J. Morphol. Embryol. 2015, 56(2 Suppl), 659–663.
   PubMed Web of Science ®Google Scholar
• Wiesner, T.; Kutzner, H.; Cerroni, L.; Mihm, M.C. Jr.; Busam, K.J.; Murali, R. Genomic Aberrations in Spitzoid Melanocytic Tumours and Their Implications for Diagnosis, Prognosis and Therapy. Pathology 2016, 48(2), 113–131.
   PubMed Web of Science ®Google Scholar
• Birner, P.; Berghoff, A.S.; Dinhof, C.; Pirker, C.; Capper, D.; Schoppmann, S.F.; Petzelbauer, P.; von Deimling, A.; Berger, W.; Preusser, M. MAP Kinase Activity Supported by BRAF (V600E) Mutation Rather than Gene Amplification is Associated with ETV1 Expression in Melanoma Brain Metastases. Arch. Dermatol. Res. 2014, 306(10), 873–884.
   PubMed Web of Science ®Google Scholar
• Lázár, V. Characterization of Genetic Alterations in Primary Human Melanomas Carrying BRAF or NRAS Mutation. Magy. Onkol. 2013, 57(2), 96–99.
   PubMedGoogle Scholar
• Rakosy, Z.; Ecsedi, S.; Toth, R.; Vizkeleti, L.; Hernandez-Vargas, H.; Lazar, V.; Emri, G.; Szatmari, I.; Herceg, Z.; Adany, R.; Balazs, M. Integrative Genomics Identifies Gene Signature Associated with Melanoma Ulceration. PLoS One. 2013, 8(1), e54958.
   PubMed Web of Science ®Google Scholar
• Baker, M.J.; Goldstein, A.M.; Gordon, P.L.; Harbaugh, K.S.; Mackley, H.B.; Glantz, M.J.; Drabick, J.J. An Interstitial Deletion within 9p21.3 and Extending Beyond CDKN2A Predisposes to Melanoma, Neural System Tumours and Possible Haematological Malignancies. J. Med. Genet. 2016, pii, jmedgenet-2015-103446.
   Google Scholar
• Yang, X.R.; Brown, K.; Landi, M.T.; Ghiorzo, P.; Badenas, C.; Xu, M.; Hayward, N.K.; Calista, D.; Landi, G.; Bruno, W.; Bianchi-Scarrà, G.; Aguilera, P.; Puig, S.; Goldstein, A.M.; Tucker, M.A. Duplication of CXC Chemokine Genes on Chromosome 4q13 in a Melanoma-prone Family. Pigment Cell Melanoma Res. 2012, 25(2), 243–247.
   PubMed Web of Science ®Google Scholar
• Neagu, M.; Constantin, C.; Zurac, S. Immune Parameters in the Prognosis and Therapy Monitoring of Cutaneous Melanoma Patients: Experience, Role, and Limitations. Biomed. Res. Int. 2013, 107940.
   PubMed Web of Science ®Google Scholar
• Neagu, M.; Constantin, C.; Manda, G.; Margaritescu, I. Biomarkers of Metastatic Melanoma. Biomark. Med. 2009, 3(1), 71–89.
   PubMed Web of Science ®Google Scholar
• Neagu, M.; Constantin, C.; Longo, C. Chemokines in the Melanoma Metastasis Biomarkers Portrait. J. Immunoass. Immunochem. 2015, 36(6), 559–566.
   PubMedGoogle Scholar
• Neagu, M.; Caruntu, C.; Constantin, C.; Boda, D.; Zurac, S.; Spandidos, D.A.; Tsatsakis, A.M. Chemically Induced Skin Carcinogenesis: Updates in Experimental Models (Review). Oncol Rep. 2016, 35(5), 2516–2528.
   PubMed Web of Science ®Google Scholar
• Namiki, T.; Tanemura, A.; Valencia, J.C.; Coelho, S.G.; Passeron, T.; Kawaguchi, M.; Vieira, W.D.; Ishikawa, M.; Nishijima, W.; Izumo, T.; Kaneko, Y.; Katayama, I.; Yamaguchi, Y.; Yin, L.; Polley, E.C.; Liu, H.;, Kawakami, Y.; Eishi, Y.; Takahashi, E.; Yokozeki, H.; Hearing, V.J. AMP Kinase-related kinase NUAK2 Affects Tumor Growth, Migration, and Clinical Outcome of Human Melanoma. Proc. Natl. Acad. Sci. USA, 2011, 108( 16), 6597–6602.
   Google Scholar
• Namiki, T.; Yaguchi, T.; Nakamura, K.; Valencia, J.C.; Coelho, S.G.; Yin, L.; Kawaguchi, M.; Vieira, W.D.; Kaneko, Y.; Tanemura, A.; Katayama, I.; Yokozeki, H.; Kawakami, Y.; Hearing, V.J. NUAK2 Amplification Coupled with PTEN Deficiency Promotes Melanoma Development via CDK Activation. Cancer Res. 2015, 75(13), 2708–2715.
   Google Scholar
• Nambiar, S.; Mirmohammadsadegh, A.; Hengge, U.R. Cutaneous Melanoma: Fishing with Chips. Curr. Mol. Med. 2008, 8(3), 235–243.
   PubMed Web of Science ®Google Scholar